BiotechTube
Home/Alterity Therapeutics/David Stamler, M.D.
DS

David Stamler, M.D.

Chief Executive Officer

Alterity Therapeutics

Therapeutic Areas

NeuroscienceNeurodegenerative Diseases

Alterity Therapeutics Pipeline

DrugIndicationPhase
ATH434Multiple System Atrophy (MSA)Phase 2

Leadership Team at Alterity Therapeutics

GK
Geoffrey Kempler
Non-Executive Chairman
DA
Dr. Andrew S. L. Chan
Chief Scientific Officer
TC
Thomas C. Scanlin, Ph.D.
Chief Medical Officer
View full Alterity Therapeutics profile